Aeluma, Inc. announced its Q1 fiscal 2027 financial results showing a net loss of $3.8 million on $0.6 million revenue, primarily from R&D contracts. The company advanced its AI photonics technology, including high-speed photodetectors and quantum dot lasers, and finalized a purchase agreement to expand manufacturing capacity. Aeluma is also negotiating up to $30 million in CHIPS funding to support development and commercialization. Despite the loss, the company is focused on scaling AI datacom opportunities and expanding customer engagements for potential high-volume demand through 2032.
Aeluma's Q1 fiscal 2027 financial results provide context for readers following technology companies. For readers following technology stocks, here is Pluang's market snapshot as of Nov 13, 2026 03:51 WIB: out of 150 priced Technology-sector US stocks tradable on Pluang, 45 rose and 105 fell today. Notable movers include AEHR at USD 61.24 with a 6.90% decrease and 90% sell order activity, RGTI at USD 10.36 down 6.75% with 56% buy orders, and HUBS at USD 215.37 up 6.16% with nearly balanced buy and sell orders.
Super League Enterprise, a company specializing in audience intelligence and media activation for the gaming industry, announced it will release its financial results for the third quarter ending September 30, 2026, on November 16, 2026, after market...
Stantec Inc. reported a 9.4% increase in net revenue to $1.9 billion for Q3 2026, driven by organic and acquisition growth. Adjusted EBITDA rose 16.6% to $377.1 million with a record margin of 20.2%, while adjusted EPS grew 23.5% to $1.89. The compan...
Siemens reported earnings per share of $1.62 and revenue of $26.28 billion, both exceeding analyst expectations. The company saw record orders and double-digit revenue growth in its smart infrastructure and digital industries units, prompting it to r...
ASUS has introduced a broad ecosystem of AI-ready hardware and software designed for gamers, creators, developers, and enterprises. The ASUS Agent Computer initiative enables users to deploy AI locally, in the cloud, or via hybrid models, offering co...
The global cosmetic peptide synthesis market is projected to grow from $274 million in 2027 to $354.85 million by 2032, with a CAGR of 5.34%. Growth is fueled by rising demand for advanced anti-aging skincare ingredients, increased use of peptide-bas...
